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background: Access site hematomas are the most frequent complication of peripheral vascular interventions (PVI) and increase length of 
hospitalization and costs; however, the risk factors for access site hematomas after PVI remain uncertain.
methods: The Vascular Quality Initiative Registry is a multicenter, prospective registry of patients undergoing major vascular procedures in the U.S. 
Univariate and multivariate analyses of 27,046 PVI procedures from August 2007 to May 2013 were performed to identify demographic, clinical and 
procedural predictors of access site hematomas.
results: Bleeding occurred in 936 patients (3.5%). On multivariate analysis, several significant predictors of access site hematoma were identified 
(Figure). Preprocedural predictors were age, gender, race, ambulatory status, prior PVI and urgency of procedure; procedural predictors were arterial 
access site, use of bivalirudin, no utilization of closure devices, use of 7- or 8-Fr sheaths, duration of fluoroscopy, arterial dissection and arterial 
perforation.
conclusion: Several factors independently predict post-PVI access site hematomas, most notably gender, ambulatory status, urgency of procedure, 
arterial access site, sheath size and arterial perforation. Knowledge of these findings could be useful when employing strategies to reduce access 
site bleeding risk and improve outcomes after PVI.
